A different study showed that cancer-associated fibroblasts induce HMGB1 (high mobility group box 1), a chromatin-associated nuclear protein released from dying tumor cells that has been suggested to mediate cancer progression and resistance to doxorubicin [126]. This evidence concerns the gene HMGB1 and neoplasm.